Gregory Demopulos
Chief Executive Officer en OMEROS CORPORATION .
Fortuna: 7 M $ al 31/03/2024
Cargos activos de Gregory Demopulos
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OMEROS CORPORATION | Chief Executive Officer | 16/06/1994 | - |
| Chairman | 16/06/1994 | - | |
| Founder | 05/10/2009 | - | |
| President | 16/06/1994 | - | |
| Chief Tech/Sci/R&D Officer | 16/06/1994 | 03/05/2010 | |
| Director of Finance/CFO | 03/05/2010 | 17/10/2013 | |
| Treasurer | 03/05/2010 | 19/06/2014 | |
Tessera, Inc.
 Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Director/Board Member | - | - |
Onconome, Inc.
 Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Director/Board Member | - | - |
| Smead Funds Trust | Director/Board Member | - | - |
| Northwest NeuroNeighborhood | Director/Board Member | - | - |
Historial de carrera de Gregory Demopulos
Formación de Gregory Demopulos.
| Stanford University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Israel | 2 |
Operativa
| Director/Board Member | 4 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| Empresas privadas | 4 |
|---|---|
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Health Technology |
| Smead Funds Trust | Miscellaneous |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Electronic Technology |
| Northwest NeuroNeighborhood |
- Bolsa de valores
- Insiders
- Gregory Demopulos
- Experiencia
